99 related articles for article (PubMed ID: 8659199)
21. Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X.
Lanza GA; Colonna G; Pasceri V; Maseri A
Am J Cardiol; 1999 Oct; 84(7):854-6, A8. PubMed ID: 10513787
[TBL] [Abstract][Full Text] [Related]
22. [Antihypertensive therapy in arterial occlusive disease].
Diehm C
Vasa Suppl; 1991; 33():71-4. PubMed ID: 1686338
[TBL] [Abstract][Full Text] [Related]
23. Effects of buflomedil in a group of patients with chronic peripheral arterial diseases. Clinical and hemorheological evaluation.
Mozzi E; Chiurazzi D; Spinola A; Annoni F; Germiniani R
J Int Med Res; 1985; 13(6):317-21. PubMed ID: 4076530
[TBL] [Abstract][Full Text] [Related]
24. Different effects of beta-1-adrenergic blocking agents with ISA or without ISA on peripheral blood flow.
Karnik R; Valentin A; Slany J
Angiology; 1987 Apr; 38(4):296-303. PubMed ID: 2883920
[TBL] [Abstract][Full Text] [Related]
25. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
Döring G
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
[TBL] [Abstract][Full Text] [Related]
26. Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug.
Straka RJ; Fish JT; Benson SR; Suh JT
Pharmacotherapy; 1997; 17(1):126-32. PubMed ID: 9017773
[TBL] [Abstract][Full Text] [Related]
27. Low-dose intermittent urokinase therapy in chronic symptomatic end-stage arterial disease--clinical relevance for patients with coronary artery disease or peripheral arterial occlusive disease.
Leschke M; Schoebel FC; Strauer BE
Clin Hemorheol Microcirc; 1997; 17(1):59-66. PubMed ID: 9181759
[TBL] [Abstract][Full Text] [Related]
28. [Intravenous administration of PGE1: studies of the effectiveness and duration of the effect of various dosages based on flow measurements of the femoral artery in patients with healthy vessels and in stage IIb arterial occlusive disease].
Scheffler P; Birkel L; Grub KR; de la Hamette D
Vasa Suppl; 1988; 23():126-9. PubMed ID: 3061035
[No Abstract] [Full Text] [Related]
29. [Use of selective long-acting beta-blocker with vasodilating activity celiprolol in patients with essential hypertension].
Podzolkov VI; Mozharova LG
Kardiologiia; 2002; 42(10):22-6. PubMed ID: 12494052
[TBL] [Abstract][Full Text] [Related]
30. [Isosorbide-5-mononitrate in silent ischemia].
Pichler M; Brandt D; Teubl H; Dorda W
Wien Klin Wochenschr; 1995; 107(13):390-5. PubMed ID: 7638969
[TBL] [Abstract][Full Text] [Related]
31. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
[No Abstract] [Full Text] [Related]
32. Celiprolol and atenolol in angina--effects on left ventricular function.
Dargie H; McLenachan JM; Wilson JT
J Int Med Res; 1988; 16 Suppl 1():47A-51A. PubMed ID: 2906017
[TBL] [Abstract][Full Text] [Related]
33. Long-term reduction of peripheral resistance with celiprolol and effects on left ventricular mass.
Trimarco B; Lembo G; DeLuca N; Ricciardelli B; Rosiello G; Volpe M; Orofino G; Condorelli M
J Int Med Res; 1988; 16 Suppl 1():62A-72A. PubMed ID: 2906018
[TBL] [Abstract][Full Text] [Related]
34. [Stress echocardiography--a new test for evaluating the anti-ischemic effect of medication].
Leischik R; Adamczewski O; Pötter S; Erbel R; Lösse B
Z Kardiol; 1995 Aug; 84(8):621-32. PubMed ID: 7571769
[TBL] [Abstract][Full Text] [Related]
35. Attenuation of adenosine-induced myocardial perfusion heterogeneity by atenolol and other cardioselective beta-adrenoceptor blockers: a crossover myocardial perfusion imaging study.
Reyes E; Stirrup J; Roughton M; D'Souza S; Underwood SR; Anagnostopoulos C
J Nucl Med; 2010 Jul; 51(7):1036-43. PubMed ID: 20554740
[TBL] [Abstract][Full Text] [Related]
36. Influence of changes in arterial blood pressure and peripheral arterial resistance on peak systolic velocity ratio.
Kröger K; Massalha K; Rudofsky G
Vasa; 1998 Aug; 27(3):163-6. PubMed ID: 9747152
[TBL] [Abstract][Full Text] [Related]
37. [Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine].
Blasini R; Brügmann U; Reiniger G; Rudolph W
Herz; 1985 Jun; 10(3):163-71. PubMed ID: 3926613
[TBL] [Abstract][Full Text] [Related]
38. Lack of effect of nitrates on exercise stress test results in patients with microvascular angina.
Russo G; Di Franco A; Lamendola P; Tarzia P; Nerla R; Stazi A; Villano A; Sestito A; Lanza GA; Crea F
Cardiovasc Drugs Ther; 2013 Jun; 27(3):229-34. PubMed ID: 23338814
[TBL] [Abstract][Full Text] [Related]
39. [Comparative studies of the effect of a cardioselective and a noncardioselective beta-blocker on peripheral circulation in patients with arterial occlusive disease].
Klieber M; Resch F
Wien Klin Wochenschr; 1986 Feb; 98(3):70-3. PubMed ID: 2938341
[TBL] [Abstract][Full Text] [Related]
40. Adding beta-2 agonism does not improve beta-1 blockade exercise responses in hypertensives.
Rueckert PA; Slane PR; Hanson P
Med Sci Sports Exerc; 1994 Aug; 26(8):945-50. PubMed ID: 7968427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
